Quetiapine XR Versus Sertraline in Acute Bipolar Depression as add-on Therapy
Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
Prospective, open-label, controlled (active comparator), randomized study of 8 weeks
follow-up for the evaluation of the efficacy of extended release quetiapine (quetiapine XR)
versus Sertraline in addition to previous mood stabilizer treatment (lithium or valproate at
stable and clinically therapeutic blood levels) in the treatment of the adult bipolar
depression. This multicentric study will be featured in two sites in Spain.